• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有黏附聚合物微贴片的中性粒细胞作为无药物的癌症免疫疗法。

Neutrophils bearing adhesive polymer micropatches as a drug-free cancer immunotherapy.

机构信息

Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, USA.

Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.

出版信息

Nat Biomed Eng. 2024 May;8(5):579-592. doi: 10.1038/s41551-024-01180-z. Epub 2024 Feb 29.

DOI:10.1038/s41551-024-01180-z
PMID:38424352
Abstract

Tumour-associated neutrophils can exert antitumour effects but can also assume a pro-tumoural phenotype in the immunosuppressive tumour microenvironment. Here we show that neutrophils can be polarized towards the antitumour phenotype by discoidal polymer micrometric 'patches' that adhere to the neutrophils' surfaces without being internalized. Intravenously administered micropatch-loaded neutrophils accumulated in the spleen and in tumour-draining lymph nodes, and activated splenic natural killer cells and T cells, increasing the accumulation of dendritic cells and natural killer cells. In mice bearing subcutaneous B16F10 tumours or orthotopic 4T1 tumours, intravenous injection of the micropatch-loaded neutrophils led to robust systemic immune responses, a reduction in tumour burden and improvements in survival rates. Micropatch-activated neutrophils combined with the checkpoint inhibitor anti-cytotoxic T-lymphocyte-associated protein 4 resulted in strong inhibition of the growth of B16F10 tumours, and in complete tumour regression in one-third of the treated mice. Micropatch-loaded neutrophils could provide a potent, scalable and drug-free approach for neutrophil-based cancer immunotherapy.

摘要

肿瘤相关中性粒细胞可以发挥抗肿瘤作用,但在免疫抑制性肿瘤微环境中也可以表现出促肿瘤表型。在这里,我们表明,通过圆盘状聚合物微尺寸“补丁”可以将中性粒细胞向抗肿瘤表型极化,这些“补丁”附着在中性粒细胞表面而不被内化。静脉内给予负载微补丁的中性粒细胞在脾脏和肿瘤引流淋巴结中积累,并激活脾脏自然杀伤细胞和 T 细胞,增加树突状细胞和自然杀伤细胞的积累。在皮下 B16F10 肿瘤或原位 4T1 肿瘤的小鼠中,静脉注射负载微补丁的中性粒细胞导致强烈的全身免疫反应,肿瘤负担减少,生存率提高。微补丁激活的中性粒细胞与检查点抑制剂抗细胞毒性 T 淋巴细胞相关蛋白 4 结合,导致 B16F10 肿瘤的强烈抑制,并使三分之一接受治疗的小鼠完全消退肿瘤。负载微补丁的中性粒细胞可为基于中性粒细胞的癌症免疫治疗提供一种有效、可扩展且无药物的方法。

相似文献

1
Neutrophils bearing adhesive polymer micropatches as a drug-free cancer immunotherapy.载有黏附聚合物微贴片的中性粒细胞作为无药物的癌症免疫疗法。
Nat Biomed Eng. 2024 May;8(5):579-592. doi: 10.1038/s41551-024-01180-z. Epub 2024 Feb 29.
2
Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.癌症相关成纤维细胞靶向策略增强基于树突状细胞疫苗的抗肿瘤免疫反应。
Cancer Sci. 2015 Feb;106(2):134-42. doi: 10.1111/cas.12584. Epub 2015 Jan 16.
3
Formyl peptide enhances cancer immunotherapy by activating antitumoral neutrophils, and T cells.甲酰肽通过激活抗肿瘤中性粒细胞和 T 细胞增强癌症免疫疗法。
Biomed Pharmacother. 2024 Jun;175:116670. doi: 10.1016/j.biopha.2024.116670. Epub 2024 Apr 30.
4
Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer models.非病毒免疫电基因疗法可诱导强烈的抗肿瘤反应,并在小鼠结肠腺癌和黑色素瘤癌症模型中具有治疗效果。
Gene Ther. 2015 Jan;22(1):29-39. doi: 10.1038/gt.2014.95. Epub 2014 Nov 6.
5
Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy.淋巴结投递策略可激活细胞毒性 T 淋巴细胞和自然杀伤细胞,增强癌症免疫治疗。
ACS Appl Mater Interfaces. 2021 May 19;13(19):22213-22224. doi: 10.1021/acsami.1c03709. Epub 2021 May 6.
6
Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.在免疫激活剂进行成功的肿瘤免疫治疗期间,单核细胞衍生的树突状细胞的数量增加。
J Immunol. 2013 Aug 15;191(4):1984-92. doi: 10.4049/jimmunol.1301135. Epub 2013 Jul 15.
7
Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.原花青素葡萄糖基转移酶通过靶向髓系来源的抑制细胞增强 PD-1 抑制的抗肿瘤作用。
J Immunother Cancer. 2019 Aug 28;7(1):231. doi: 10.1186/s40425-019-0676-z.
8
Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.靶向 CAMKII 重塑肿瘤相关巨噬细胞并抑制肿瘤细胞的可注射杂合肽水凝胶用于癌症免疫治疗。
Theranostics. 2020 Feb 10;10(7):3049-3063. doi: 10.7150/thno.42385. eCollection 2020.
9
Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo.电离辐射与热疗相结合可在体外和体内提高B16-F10黑色素瘤细胞的免疫原性潜力。
Int J Hyperthermia. 2016;32(1):23-30. doi: 10.3109/02656736.2015.1106011. Epub 2016 Jan 11.
10
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.肿瘤内免疫疗法采用 TLR7/8 激动剂 MEDI9197 调节肿瘤微环境,与其他免疫疗法联合使用时可增强其活性。
J Immunother Cancer. 2019 Sep 11;7(1):244. doi: 10.1186/s40425-019-0724-8.

引用本文的文献

1
Particle Shape Modulates the Function of Adoptive Macrophage Transfers.颗粒形状调节过继性巨噬细胞转移的功能。
Adv Healthc Mater. 2025 Aug 7:e01348. doi: 10.1002/adhm.202501348.
2
Technology Roadmap of Micro/Nanorobots.微纳机器人技术路线图
ACS Nano. 2025 Jul 15;19(27):24174-24334. doi: 10.1021/acsnano.5c03911. Epub 2025 Jun 27.
3
Nanoparticle-Based Pulmonary Immune Engineering.基于纳米颗粒的肺部免疫工程

本文引用的文献

1
Backpack-mediated anti-inflammatory macrophage cell therapy for the treatment of traumatic brain injury.背包介导的抗炎巨噬细胞疗法治疗创伤性脑损伤
PNAS Nexus. 2023 Dec 13;3(1):pgad434. doi: 10.1093/pnasnexus/pgad434. eCollection 2024 Jan.
2
Preclinical characterization of macrophage-adhering gadolinium micropatches for MRI contrast after traumatic brain injury in pigs.创伤性脑损伤后猪模型中巨噬细胞黏附型钆微贴片的磁共振成像对比剂的临床前特征。
Sci Transl Med. 2024 Jan 3;16(728):eadk5413. doi: 10.1126/scitranslmed.adk5413.
3
Polymer Micropatches as Natural Killer Cell Engagers for Tumor Therapy.
Annu Rev Chem Biomol Eng. 2025 Jun;16(1):249-270. doi: 10.1146/annurev-chembioeng-082223-105117. Epub 2025 Mar 12.
4
Harnessing myeloid cells in cancer.利用癌症中的髓样细胞。
Mol Cancer. 2025 Mar 6;24(1):69. doi: 10.1186/s12943-025-02249-2.
5
Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review).肿瘤相关中性粒细胞:癌症进展和治疗耐药性的关键调节因子(综述)
Int J Oncol. 2025 Apr;66(4). doi: 10.3892/ijo.2025.5734. Epub 2025 Feb 28.
6
Cell carriers change the fate of nanoparticles.细胞载体改变纳米颗粒的命运。
Acta Pharm Sin B. 2024 Dec;14(12):5515-5517. doi: 10.1016/j.apsb.2024.08.011. Epub 2024 Aug 14.
7
Activated neutrophils: A next generation cellular immunotherapy.活化中性粒细胞:新一代细胞免疫疗法。
Bioeng Transl Med. 2024 Aug 13;10(1):e10704. doi: 10.1002/btm2.10704. eCollection 2025 Jan.
8
Immunotherapy against glioblastoma using backpack-activated neutrophils.利用背负式激活中性粒细胞治疗胶质母细胞瘤的免疫疗法。
Bioeng Transl Med. 2024 Aug 13;10(1):e10712. doi: 10.1002/btm2.10712. eCollection 2025 Jan.
9
Tailoring cell-inspired biomaterials to fuel cancer therapy.定制受细胞启发的生物材料以推动癌症治疗。
Mater Today Bio. 2024 Dec 6;30:101381. doi: 10.1016/j.mtbio.2024.101381. eCollection 2025 Feb.
10
Knowledge landscape of tumor-associated neutrophil: a bibliometric and visual analysis from 2000-2024.肿瘤相关中性粒细胞的知识图谱:2000-2024 年的文献计量学和可视化分析。
Front Immunol. 2024 Oct 4;15:1448818. doi: 10.3389/fimmu.2024.1448818. eCollection 2024.
聚合物微贴作为自然杀伤细胞激活物用于肿瘤治疗。
ACS Nano. 2023 Aug 22;17(16):15918-15930. doi: 10.1021/acsnano.3c03980. Epub 2023 Aug 11.
4
A backpack-based myeloid cell therapy for multiple sclerosis.背包式骨髓细胞疗法治疗多发性硬化症。
Proc Natl Acad Sci U S A. 2023 Apr 25;120(17):e2221535120. doi: 10.1073/pnas.2221535120. Epub 2023 Apr 19.
5
A neutrophil response linked to tumor control in immunotherapy.免疫治疗中与肿瘤控制相关的中性粒细胞反应。
Cell. 2023 Mar 30;186(7):1448-1464.e20. doi: 10.1016/j.cell.2023.02.032.
6
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants.T 细胞免疫疗法利用中性粒细胞消除肿瘤抗原逃逸变体。
Cell. 2023 Mar 30;186(7):1432-1447.e17. doi: 10.1016/j.cell.2023.03.007.
7
Neutrophil-activating therapy for the treatment of cancer.中性粒细胞激活治疗癌症。
Cancer Cell. 2023 Feb 13;41(2):356-372.e10. doi: 10.1016/j.ccell.2023.01.002. Epub 2023 Jan 26.
8
NK cells and solid tumors: therapeutic potential and persisting obstacles.自然杀伤细胞与实体瘤:治疗潜力与持续存在的障碍。
Mol Cancer. 2022 Nov 1;21(1):206. doi: 10.1186/s12943-022-01672-z.
9
Natural killer cells in antitumour adoptive cell immunotherapy.肿瘤过继细胞免疫治疗中的自然杀伤细胞
Nat Rev Cancer. 2022 Oct;22(10):557-575. doi: 10.1038/s41568-022-00491-0. Epub 2022 Jul 25.
10
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies.嵌合抗原受体 T 细胞疗法的细胞因子释放综合征和神经毒性的机制及相关预防和管理策略。
J Exp Clin Cancer Res. 2021 Nov 18;40(1):367. doi: 10.1186/s13046-021-02148-6.